Nursing homes; Nursing Homes Care Act; definition; effective date.
HB1674 is a technical amendment to Oklahoma’s Nursing Home Care Act that updates and expands the statute’s definitions section. The bill revises the list of defined terms used in the Act, including terms such as “facility,” “nursing facility,” “specialized facility,” “residential care home,” “owner,” “resident,” “representative of a resident,” and “supportive assistance.” It also adds or clarifies language around “medication preparation,” specifying that licensed nurses may prepare medications for administration, including reconstitution, within the scope of their licensure.
The bill appears to be largely definitional and administrative rather than a broad policy overhaul. It preserves existing distinctions among nursing facilities, specialized facilities, residential care homes, and adult companion homes, while refining how those categories are described for regulatory and licensing purposes. The measure is set to take effect on November 1, 2025.
HB1674 would amend 63 O.S. 2021, Section 1-1902, which is the definitions section of the Nursing Home Care Act. Its legal effect is to change how the Act is interpreted and applied by the Oklahoma Department of Health, nursing facilities, specialized facilities, residential care homes, owners, administrators, residents, and resident representatives. Because the bill is definitional, it may affect licensing, compliance, enforcement, and facility classification without directly creating new substantive care requirements.
The available legislative history shows little overt controversy or debate. There are no committee transcripts or recorded votes in the provided materials, and the bill’s status indicates it was referred to Rules after second reading. Based on the text alone, the measure appears to be a routine housekeeping update to clarify statutory terms in the nursing home regulatory framework, suggesting a generally neutral or procedural sentiment.
No specific points of contention are documented in the provided record. Potential areas of interest, based on the text, could include the expanded definition of “owner” for certain nonstate governmental entities participating in the supplemental payment program, the clarification of who may prepare medications, and the detailed distinctions among facility types. However, there is no evidence in the supplied materials that any of these issues were actively disputed by legislators or stakeholders.